{"title":"微小核糖核酸生物标志物：陷阱和潜力。","authors":"Mary Bates","doi":"10.1109/MPULS.2023.3294086","DOIUrl":null,"url":null,"abstract":"<p><p>Thirty years ago, the small molecules we now know as microRNAs (miRNAs) would have been regarded as \"junk\" genetic material. Today, miRNAs have been hailed as promising biomarkers for diseases including cancer, neurological disorders, heart conditions, and infections. Although progress has been made toward characterizing the role of miRNAs in different diseases, there remain challenges in bringing them into clinical use. Researchers continue to explore where miRNAs will make the most impact.</p>","PeriodicalId":49065,"journal":{"name":"IEEE Pulse","volume":null,"pages":null},"PeriodicalIF":0.3000,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"MicroRNA Biomarkers: Pitfalls and Potential.\",\"authors\":\"Mary Bates\",\"doi\":\"10.1109/MPULS.2023.3294086\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Thirty years ago, the small molecules we now know as microRNAs (miRNAs) would have been regarded as \\\"junk\\\" genetic material. Today, miRNAs have been hailed as promising biomarkers for diseases including cancer, neurological disorders, heart conditions, and infections. Although progress has been made toward characterizing the role of miRNAs in different diseases, there remain challenges in bringing them into clinical use. Researchers continue to explore where miRNAs will make the most impact.</p>\",\"PeriodicalId\":49065,\"journal\":{\"name\":\"IEEE Pulse\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.3000,\"publicationDate\":\"2023-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"IEEE Pulse\",\"FirstCategoryId\":\"5\",\"ListUrlMain\":\"https://doi.org/10.1109/MPULS.2023.3294086\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"ENGINEERING, BIOMEDICAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"IEEE Pulse","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1109/MPULS.2023.3294086","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
Thirty years ago, the small molecules we now know as microRNAs (miRNAs) would have been regarded as "junk" genetic material. Today, miRNAs have been hailed as promising biomarkers for diseases including cancer, neurological disorders, heart conditions, and infections. Although progress has been made toward characterizing the role of miRNAs in different diseases, there remain challenges in bringing them into clinical use. Researchers continue to explore where miRNAs will make the most impact.
期刊介绍：
IEEE Pulse covers both general and technical articles on current technologies and methods used in biomedical and clinical engineering; societal implications of medical technologies; current news items; book reviews; patent descriptions; and correspondence. Special interest departments, students, law, clinical engineering, ethics, new products, society news, historical features and government.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
